J.P. Morgan: Genapsys

Genapsys' J.P. Morgan presentation by CEO Hesaam Esfandyarpour focused on their story of delivering a compact sequencer based on electronic detection that offers low capital, low cost sequencing.   There were two bits of specific product news, but mostly general painting of a rosy picture.  Read more »

Source: Omics! Omics! - January 25, 2021 Category: Bioinformatics Authors: Keith Robison Source Type: blogs